Chemotherapy with platinum-based regimens is the standard of care for advanced-stage non-small cell lung cancer (NSCLC). However, reliable genetic variations for the prediction of response and overall survival to platinum-based therapy are still not well established. In this three-stage genome-wide association study, we identified five single nucleotide polymorphisms (SNP) as markers for survival of advanced-stage NSCLC patients treated with first-line platinum-based chemotherapy in Chinese Han populations. Two of these SNPs, rs7629386 and rs3850370, could also be markers for survival among Caucasian patients. were associated with better NSCLC survival. In addition, rs7629386 at 3p22.1 (CTNNB1) and rs3850370 at 14q24.3 (SNW1-ALKBH1-NRXN3) were further replicated in the Caucasian population.
INTRODUCTION
Lung cancer, predominantly non-small-cell lung cancer (NSCLC), is the leading cause of cancer-related deaths worldwide; five-year survival rates are only 15.1% in China (1) .The current standard treatment for patients with early stage NSCLC is surgical resection, with or without adjuvant chemotherapy (2, 3) . However, most patients are diagnosed at advanced stage, where platinum-based chemotherapy is the mainstay of treatment. Response to therapy varies considerably between patients (4).
The traditional TNM staging system is not useful for predicting response to therapy, and molecular biomarkers can add value in this setting (5, 6) . It has been suggested that the discovery and application of molecular biomarkers to incorporate with traditional clinical prognostic factors could guide individualized treatment and improve the outcomes of cancer patients (7) . Many studies have been conducted to explore single-nucleotide polymorphisms (SNPs) in candidate genes and overall survival in NSCLC, including studies from our groups (8) (9) (10) (11) (12) . Genome-wide association studies (GWAS), which make no assumptions about the genomic location of the causal variants, are expected to complement the candidate gene approach.
Here, we conducted a GWAS scan by genotyping 906,703 SNPs for association with survival in 535 Han Chinese with advanced NSCLC. Fast-track replication was conducted in an independent NSCLC cohort from Southeastern China followed by further validation in NSCLC patients from the Massachusetts General Hospital in Boston, MA, USA.
MATERIALS AND METHODS

Study populations
The discovery phase of the study included two groups of advanced NSCLC patients from Nanjing and Beijing described previously in our GWAS study on lung cancer susceptibility (13) . In order to construct a relatively homogenous population with same treatment, our current study was restricted to stage III or IV NSCLC patients Nanjing Thoracic Hospital and Shanghai Chest Hospital (Southeastern China) (14) , and the second replication included 409 NSCLC patients from the Massachusetts General Hospital, Boston, USA (Harvard cohort) (15) . Subjects in the discovery phase and the first replication phase were all unrelated Han Chinese, and those in the second replication set were Caucasian. All patients had histopathologically or cytologically confirmed NSCLC which was reviewed by at least two local pathologists. Informed consent was obtained from each subject at the time of recruitment, and this study was approved by the Institutional Review Boards of each participating institution.
Quality Control (QC) in GWAS
Before the survival analysis, we conducted systematic QC on the raw genotyping data to filter both unqualified samples and SNPs, as described previously (13) . SNPs were excluded if: (i) SNPs were not mapped on autosomal chromosomes; (ii) SNPs had a call rate <95%; or (iii) SNPs had minor allele frequency (MAF) < 0.05. Samples with low call rates (< 95%), ambiguous gender, familial relationships (PI_HAT > 0.25), outliers in the principal component analysis and extreme heterozygote rate (> 6 standard deviation from nearest neighbor) were removed. Finally, 303 cases were used for the Nanjing study, and 225 cases for the Beijing study with 576,351 overlapped SNPs.
SNPs selection and genotyping
Genome-wide association analysis was performed using the additive model by multivariate Cox regression analysis with adjustment for age, gender, smoking status, histology and stage in each of the discovery studies. Meta-analysis on Nanjing and Beijing discovery samples were then performed based on fixed or random models.
For fast-track replication, we selected 33 top SNPs that had (i) P <1×10 -4 for all GWAS samples and (ii) a consistent association at P < 0.05 in both the Nanjing study
Research. with the 12 selected SNPs. Five SNPs that were found to be associated with overall survival at P values lower than 0.05 (in any genetic model) and had the same association direction as the GWAS scan were further genotyped in the second validation set. Genotyping for the validation populations was done using TaqMan allelic discrimination assay on an ABI 7900 system (Applied Biosystems), except one (rs3850370) by SNP chip (Illumina 610k Quad, Call rate: 100%), and one (rs41997) by imputation analysis using the LD information from the 1000 Genomes Project database (by MACH, the estimated squared correlation (r 2 ) between imputed and true underlying genotypes is 1.00, indicating an excellent imputation quality) for the Harvard cohort. The information on primers and probes are available upon request.
Ten percent random samples were reciprocally tested on the TaqMan assay, and the reproducibility was 100%.
Statistical Analysis
Overall survival time was calculated from the time of diagnosis until death or the latest follow-up. We used PLINK 1.07 for general statistical analysis (16 (17) . Region plot was generated using an online tool, LocusZoom 1.1
(http://csg.sph.umich.edu/locuszoom/). Analyses was also performed using SAS version 9.1.3 (SAS Institute, Cary, NC) or Stata version 9.2 (StataCorp LP, TX).
RESULTS
The characteristics of the NSCLC patients in the two discovery cohorts and the two
Research. Table 1 ). We selected 12 SNPs (21 SNPs excluded) to perform the validation using an independent NSCLC cohort from Southeastern China. For the 12 SNPs, five SNPs at 3p22.1 (rs7629386), 5p14.1 (rs969088), 7q31.31 (rs41997), 9p21.3 (rs12000445) and 14q24.3 (rs3850370) were found to be associated with overall survival in the same direction as the GWAS scan with P values lower than 0.05 (rs41997 and rs12000445 in additive genetic model, while rs7629386, rs969088 and rs3850370 in homozygote comparison) ( Table 2 ). For all Chinese samples, the 5 SNPs were associated with NSCLC survival with P meta (additive) values ranging from 3.63×10 −5 to 4.19×10 −7 , with 3 (the minor allele of rs7629386, rs969088 and rs3850370) being associated with worse survival while 2 (the minor allele of rs41997 and rs12000445) were associated with improved survival (Table 2) .
We further validated these 5 SNPs in Harvard cohort samples. Four SNPs (rs7629386, rs969088, rs12000445 and rs3850370) had same direction of association (Table 3 , Supplementary Figure 1 ), but only rs7629386 at 3p22.1 (homozygote comparison) and rs3850370 at 14q24.3 (additive model) had significant association with NSCLC survival (Table 3 We only observed slightly heterogeneity in the HRs for rs41997 among histological subtypes (P = 0.050).
DISCUSSION
Research. (18) . However, rs1878022 and rs10937823 were both non-significantly associated with NSCLC death risk in our GWAS scan samples (rs1878022: HR=1.10, P =0.204; rs10937823: HR=0.89, P = 0.336)( Supplementary Figure 5A ,5B).
The SNP rs3850370 at 14q24.3 can modify survival in NSCLC across Chinese and Caucasian populations. rs3850370 is located among three genes: Ski-interacting protein (SKIIP, known also as SNW1, upstream 307kb), alkylation repair homolog 1 (ALKBH1, downstream 360kb) and Neurexin 3 (NRXN3, upstream 1210kb) (Supplementary Figure 6E ). SNW1 is a nuclear matrix-associated coactivator that may couple vitamin D receptor-mediated transcription and RNA splicing (19) . Using a library of endoribonuclease-prepared short interfering RNAs (esiRNAs), Kittler et al. identified that SNW1 is among the 37 genes required for cell division (20) . Recently, it was also shown that SNW1 is required for TGF-β1 induced epithelial mesenchymal transition (EMT) and invasiveness in transformed cells (21) . To date, eight human homologues of the Escherichia coli DNA repair enzyme ALKB (ALKBH1-8) have been identified, which are involved in repair of alkylation damage in DNA and RNA (22) . Among them, ALKBH3 was reported to be significantly overexpressed in lung adenocarcinoma cells and contributes to NSCLC cell survival (23) , while combined treatment modalities with cisplatin and lentivirus-mediated ALKBH2 down-regulation were significantly more potent in inhibiting lung cell growth and inducing apoptosis Our study has a number of strengths. First, this is the largest GWAS study to date to investigate overall survival in advanced NSCLC patients. Second, we used a three-stage study design with four independent cohorts. SNPs that are associated with overall survival across all study populations have a high probability of being true-positive findings, thus reducing the need for strict multiple comparison correction. 
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